Literature DB >> 21989389

Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy.

Kakulavarapu V Rama Rao1, Michael D Norenberg.   

Abstract

One proposed mechanism for acute and chronic hepatic encephalopathy (HE) is a disturbance in cerebral energy metabolism. It also reviews the current status of this mechanism in both acute and chronic HE, as well as in other hyperammonemic disorders. It also reviews abnormalities in glycolysis, lactate metabolism, citric acid cycle, and oxidative phosphorylation as well as associated energy impairment. Additionally, the role of mitochondrial permeability transition (mPT), a recently established factor in the pathogenesis of HE and hyperammonemia, is emphasized. Energy failure appears to be an important pathogenetic component of both acute and chronic HE and a potential target for therapy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21989389      PMCID: PMC4714837          DOI: 10.1016/j.neuint.2011.09.007

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  135 in total

Review 1.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

2.  Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devascularization.

Authors:  P Traber; M DalCanto; D Ganger; A T Blei
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

3.  Cerebral effects of acute ammonia intoxication. II. The effect upon energy metabolism.

Authors:  B Hindfelt; B K Siesjö
Journal:  Scand J Clin Lab Invest       Date:  1971-11       Impact factor: 1.713

Review 4.  Cerebral energy metabolism in normoxia and in hypoxia.

Authors:  B K Siesjö; F Plum
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1971

5.  Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow.

Authors:  Rajiv Jalan; Steven W M Olde Damink; Peter C Hayes; Nicolaas E P Deutz; Alistair Lee
Journal:  J Hepatol       Date:  2004-10       Impact factor: 25.083

6.  Neurotoxicity of ammonia and fatty acids: differential inhibition of mitochondrial dehydrogenases by ammonia and fatty acyl coenzyme A derivatives.

Authors:  J C Lai; A J Cooper
Journal:  Neurochem Res       Date:  1991-07       Impact factor: 3.996

7.  Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure.

Authors:  Christopher Rose; Lars M Ytrebø; Nathan A Davies; Sambit Sen; Geir I Nedredal; Mireille Belanger; Arthur Revhaug; Rajiv Jalan
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

8.  Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor.

Authors:  V Papadopoulos; P Guarneri; K E Kreuger; A Guidotti; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

9.  Effect of acute ammonia intoxication on energy stores in the cerebral reticular activating system.

Authors:  D W McCandless; S Schenker
Journal:  Exp Brain Res       Date:  1981       Impact factor: 1.972

10.  Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia.

Authors:  Wenlei Jiang; Paul Desjardins; Roger F Butterworth
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-04       Impact factor: 6.200

View more
  41 in total

1.  TGFβ1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5.

Authors:  Matthew A McMillin; Gabriel A Frampton; Andrew P Seiwell; Nisha S Patel; Amber N Jacobs; Sharon DeMorrow
Journal:  Lab Invest       Date:  2015-06-01       Impact factor: 5.662

2.  Fatal Hyperammonemic Encephalopathy in a Pediatric Patient After Roux-en-Y Gastric Bypass.

Authors:  Patrick C Bonasso; Melvin S Dassinger
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

3.  Accumulation of lactate in the rat brain during hyperammonaemia is not associated with impaired mitochondrial respiratory capacity.

Authors:  Anne Møller Witt; Fin Stolze Larsen; Peter Nissen Bjerring
Journal:  Metab Brain Dis       Date:  2016-12-07       Impact factor: 3.584

4.  Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy.

Authors:  Saurabh Dhanda; Aditya Sunkaria; Avishek Halder; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2017-11-14       Impact factor: 3.584

Review 5.  Intertissue differences for the role of glutamate dehydrogenase in metabolism.

Authors:  Jason R Treberg; Sheena Banh; Umesh Pandey; Dirk Weihrauch
Journal:  Neurochem Res       Date:  2013-02-15       Impact factor: 3.996

Review 6.  Cerebral effects of ammonia in liver disease: current hypotheses.

Authors:  Peter Ott; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2014-02-04       Impact factor: 3.584

Review 7.  Acetyl-L-carnitine in hepatic encephalopathy.

Authors:  Michele Malaguarnera
Journal:  Metab Brain Dis       Date:  2013-02-08       Impact factor: 3.584

8.  1H and 31P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: in vivo longitudinal measurements of brain energy metabolism.

Authors:  Veronika Rackayova; Olivier Braissant; Valérie A McLin; Corina Berset; Bernard Lanz; Cristina Cudalbu
Journal:  Metab Brain Dis       Date:  2015-08-09       Impact factor: 3.584

Review 9.  Update on cerebral uptake of blood ammonia.

Authors:  Michael Sørensen
Journal:  Metab Brain Dis       Date:  2013-03-13       Impact factor: 3.584

10.  Curcumin prevents cognitive deficits in the bile duct ligated rats.

Authors:  Somayeh Baghbaderani; Mehrdad Hashemi; Mohaddaseh Ebrahimi-Ghiri; Mohammad-Reza Zarrindast; Mohammad Nasehi; Maliheh Entezari
Journal:  Psychopharmacology (Berl)       Date:  2020-08-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.